Dr. SHAIFALI CHAHAR

Dr.SANTOSH G. HONAVAR

Abstract

Purpose: To evaluate the role of transconjunctival intra-levator injection of triamcinolone acetonide (TA) in upper eyelid retraction in thyroid eye disease (TED).Methods: Retrospective interventional case series of 37 eyes of 22 patients who underwent transconjunctival TA injection (40 mg/mL) into the levator palpebrae superioris (LPS) muscle for TED-related upper eyelid retraction between 2019 to 2022. Results:Mean age was 46.2 years.Pre-treatment margin-reflex distance (MRD) 1 was 6.0+/- 1.9 mm. The mean number of TA injections was 1.77 +/- 0.97.Time to maximal response was 37.6 weeks. At mean follow-up of 16.3 months, MRD1 was 4.5 +/- 1.5 mm, showing improvement in all cases. Mean reduction in MRD1 was 1.5 +/- 1.6 mm (p=0.000) and there was no regression from maximal response. None of the patients showed any complications associated with TA. Conclusion: Transconjunctival TA injection to LPS muscle is an effective treatment option for TED-related upper eyelid retraction.

Full Text